WO2001009154A3 - USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN - Google Patents
USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN Download PDFInfo
- Publication number
- WO2001009154A3 WO2001009154A3 PCT/US2000/020735 US0020735W WO0109154A3 WO 2001009154 A3 WO2001009154 A3 WO 2001009154A3 US 0020735 W US0020735 W US 0020735W WO 0109154 A3 WO0109154 A3 WO 0109154A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- isoleucyl
- staphylococcus aureus
- trna synthetase
- crystal structure
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002380335A CA2380335A1 (en) | 1999-07-29 | 2000-07-31 | Use of the crystal structure of staphylococcus aureus isoleucyl-trna synthetase in antibiotic design |
AU63915/00A AU6391500A (en) | 1999-07-29 | 2000-07-31 | Use of the crystal structure of staphylococcus aureus isoleucyl-trna synthetase in antibiotic design |
EP00950881A EP1200564A2 (en) | 1999-07-29 | 2000-07-31 | USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14617699P | 1999-07-29 | 1999-07-29 | |
US60/146,176 | 1999-07-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001009154A2 WO2001009154A2 (en) | 2001-02-08 |
WO2001009154A3 true WO2001009154A3 (en) | 2001-07-26 |
Family
ID=22516158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/020735 WO2001009154A2 (en) | 1999-07-29 | 2000-07-31 | USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN |
Country Status (5)
Country | Link |
---|---|
US (1) | US6631329B1 (en) |
EP (1) | EP1200564A2 (en) |
AU (1) | AU6391500A (en) |
CA (1) | CA2380335A1 (en) |
WO (1) | WO2001009154A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004013167A2 (en) * | 2002-08-01 | 2004-02-12 | Affinium Pharmaceuticals, Inc. | Purified polypeptides from enterococcus faecalis |
US20070118296A1 (en) * | 2003-11-07 | 2007-05-24 | Dna Software Inc. | System and methods for three dimensional molecular structural analysis |
WO2008070257A2 (en) * | 2006-09-29 | 2008-06-12 | Anacor Pharmaceuticals, Inc. | Crystal structure of a trna synthetase |
CN112933243B (en) * | 2021-01-25 | 2023-06-27 | 中山大学 | Complex crystal of isoleucyl tRNA synthetase and Lei Fumei element A, and preparation method and application thereof |
-
2000
- 2000-07-31 WO PCT/US2000/020735 patent/WO2001009154A2/en not_active Application Discontinuation
- 2000-07-31 AU AU63915/00A patent/AU6391500A/en not_active Abandoned
- 2000-07-31 EP EP00950881A patent/EP1200564A2/en not_active Withdrawn
- 2000-07-31 CA CA002380335A patent/CA2380335A1/en not_active Abandoned
- 2000-07-31 US US09/629,732 patent/US6631329B1/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
L F SILVIAN ET AL.: "Insights into editing from an Ile-t RNAS synthetase structure with tRNA and mupirocin", SCIENCE., vol. 285, 13 August 1999 (1999-08-13), AAAS. LANCASTER, PA., US, pages 1074 - 1077, XP002160175 * |
O NUREKI ET AL.: "Enzyme structure with two catalytic sites for double-sieve selection of substrates", SCIENCE., vol. 280, 24 April 1998 (1998-04-24), AAAS. LANCASTER, PA., US, pages 578 - 582, XP002160173 * |
S P HALE ET AL.: "Discrete determinants in transfer RNA for editing and aminoacylation", SCIENCE., vol. 276, 23 May 1997 (1997-05-23), AAAS. LANCASTER, PA., US, pages 1250 - 1252, XP002160174 * |
Also Published As
Publication number | Publication date |
---|---|
CA2380335A1 (en) | 2001-02-08 |
AU6391500A (en) | 2001-02-19 |
EP1200564A2 (en) | 2002-05-02 |
WO2001009154A2 (en) | 2001-02-08 |
US6631329B1 (en) | 2003-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Landini et al. | Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal | |
Abouelhassan et al. | Discovery of quinoline small molecules with potent dispersal activity against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a scaffold hopping strategy | |
Czaplewski et al. | Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ | |
UA86413C2 (en) | Normal;heading 1;heading 2;SUGAR COATING AND SOLID DOSAGE FORM CONTAINING THEREOF | |
WO2005039548A3 (en) | Use of effectors of glutaminyl and glutamate cyclases | |
CY1118065T1 (en) | INNOVATIVE AMINOGLYCOSIDES AND THEIR USES IN THE TREATMENT OF GENETIC DISORDERS | |
CA2318398A1 (en) | Novel peptides having biological activity | |
HUP0004555A2 (en) | A novel strain of bacillus for controlling plant diseases and corn rootworm | |
MY133996A (en) | Compounds for the treatment of ischemia | |
WO2007014372A3 (en) | Compositions and methods for treating bacteria | |
AU2002246411A1 (en) | Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same | |
WO2005019241A3 (en) | Cationic antimicrobial peptides and compositions thereof | |
DK0746327T3 (en) | Acidified nitrite as an antimicrobial agent | |
AU686222B2 (en) | Cyclodepsipeptide compound | |
PL1853292T3 (en) | Pharmaceutical composition comprising glutathione compounds and betalain for the prevention and treatment of cancer | |
HUP0102515A2 (en) | Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
AU9342898A (en) | Contrasting agent for infarct and necrosis imaging | |
WO2001009154A3 (en) | USE OF THE CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS ISOLEUCYL-tRNA SYNTHETASE IN ANTIBIOTIC DESIGN | |
WO1999067238A3 (en) | Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them | |
ATE388960T1 (en) | GLYCOPEPTIDE DERIVATIVES WITH CARBOXY SACCHARIDES | |
EA200500353A1 (en) | LINCOMYCIN DERIVATIVES OWNING ANTIBACTERIAL ACTIVITY | |
AU2002353768A1 (en) | 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors. | |
WO2005054172A3 (en) | Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof | |
AU2094200A (en) | Cosmetic or medical preparation for topical use | |
PL1677818T3 (en) | Stable aqueous g-csf-containing compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2380335 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000950881 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000950881 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000950881 Country of ref document: EP |